Upload
others
View
0
Download
0
Embed Size (px)
Citation preview
2017‐2018
Scientific output: >60 papers
• Cardiovascular research• Sci. Rep.• ATVB….
• Oncology research• Clinical Cancer Research• Eur. J. Cancer
IF 24.7, 2x!! (MvE IF 8.0 (MvE) IF 20.1 (MD)
IF 8.1 (MvE) IF 23.4 (AzH; EB)
IF 13.2
IF 10.8 (MD)
IF 19.9 (JS) IF 36.4 (HG)
Highlights• VENI (E vd Vorst, VM)• VIDI/ASPASIA (JS) • ERA‐CVD (lead partner; EB)• H2020/ITN (2x; EB) • KWF (MvE)• Maastricht University/Birmingham University (MD)• NWO Middelgroot (KS)• Health Holland (MvE)• Kankeronderzoeksfonds Limburg (MvE)• Contract research MDxHealth (MvE)
> 3M euro
• Carmen Rijvers• Sophie Joosten• Kosta Theodorou (cum laude)• Marchy Kietadisorn
Awards/Highlights
• Multiple poster awards (PhDs)• Paper of the year award Scandinavian Society for Atherosclerosis Research (EvdVorst/MD)
• Martin Hofker Memorial Award (MD)• Toptalent Program FHML (JS)• IMPACT training UM (MD)
(Inter)national Visibility‐I• CARIM Strategic Board (JS) • GROW (Research) Board (EB, MD)• GROW Young Investigators (VM)• GROW Director (MvE)
• NWO TOP committee member (EB)• NWO VICI committee member (MvE)• FWO‐Med6 (EB)• KWF Board of advisors (MvE)• AACR Team Science Award Committee (MvE)• Board member Pathological Society (HG)• Board member Dutch Atherosclerosis Society (EB)• Board member DEBS (JS)
International Visibility II
Societal Activities
BUT…..
Potential Threats• Scientific output compromised (50% teaching obligations)• Continuity of acquisition (and group size)• Integration Clinics‐Research (also to include research ambitions pathologists)
• Infrastructure• PhD/PD desk space limiting• Replacement of outdated/crashed key machines• Organisation